|
Video: What is a Stock Split?
|
|
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. According to our Bio-Techne stock split history records, Bio-Techne has had 3 splits. | |
|
Bio-Techne (TECH) has 3 splits in our Bio-Techne stock split history database. The first split for TECH took place on November 18, 1997. This was a 2 for 1
split, meaning for each share of TECH owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. TECH's second split took place on December 04, 2000. This was a 2 for 1 split, meaning for each share of TECH owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. TECH's third split took place on November 30, 2022. This was a 4 for 1 split, meaning for each share of TECH owned pre-split, the shareholder now owned 4 shares. For example, a 4000 share position pre-split, became a 16000 share position following the split.
When a company such as Bio-Techne splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the Bio-Techne stock split history from start to finish, an original position size of 1000 shares would have turned into 16000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bio-Techne shares, starting with a $10,000 purchase of TECH, presented on a split-history-adjusted basis factoring in the complete Bio-Techne stock split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
10/08/2014 |
|
End date: |
10/04/2024 |
|
Start price/share: |
$23.09 |
|
End price/share: |
$74.78 |
|
Starting shares: |
433.09 |
|
Ending shares: |
466.61 |
|
Dividends reinvested/share: |
$3.20 |
|
Total return: |
248.93% |
|
Average Annual Total Return: |
13.32% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$34,907.35 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/08/2014 |
|
End date: |
10/04/2024 |
|
Start price/share: |
$23.09 |
|
End price/share: |
$74.78 |
|
Dividends collected/share: |
$3.20 |
|
Total return: |
237.72% |
|
Average Annual Total Return: |
12.95% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$33,784.50 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
11/18/1997 | 2 for 1
| 12/04/2000 | 2 for 1 | 11/30/2022 | 4 for 1 |
|
|